Phase I dose expansion results of CYT-0851 plus capecitabine in platinum-resistant ovarian cancer VJOncology 0:35 3 months ago 39 Скачать Далее
Relacorilant + nab-paclitaxel in recurrent, platinum-resistant ovarian cancer VJOncology 1:19 1 year ago 234 Скачать Далее
Dr. Matulonis Discusses Niraparib/Pembrolizumab Combo in Platinum-Resistant Ovarian Cancer OncLive 2:20 6 years ago 689 Скачать Далее
Phase II Results for Niraparib in Heavily Pretreated Patients With Ovarian Cancer Targeted Oncology 3:04 6 years ago 286 Скачать Далее
First-in-human results of CDK2/4/6 inhibition in breast and ovarian cancer VJOncology 6:35 2 years ago 693 Скачать Далее
Unmet clinical needs for platinum-resistant ovarian cancer patients VJOncology 1:41 5 years ago 169 Скачать Далее
Updates on Promising Progress in Platinum Resistant Ovarian Cancer Ovarcome 28:44 9 months ago 1 102 Скачать Далее
#ESMO21 Highlights on aspirin use in recurrent platinum-resistent ovarian cancer: EORTC-1508 study European Society for Medical Oncology (ESMO) 2:42 2 years ago 1 319 Скачать Далее
Dr. Moore on Anticipated Impact of the MIRASOL Trial in Platinum-Resistant Ovarian Cancer OncLive 2:19 3 years ago 702 Скачать Далее
Dr. Moore on Early-Phase Data With Mirvetuximab Soravtansine in Ovarian Cancer OncLive 2:15 4 years ago 270 Скачать Далее
#ESMO19: FORWARD I (GOG 3011) Study for Platinum-Resistant Ovarian Cancer Society of Gynecologic Oncology 4:46 4 years ago 418 Скачать Далее
PARP Inhibitors in Platinum Sensitive & Platinum Resistant Ovarian Cancers Ovarcome 24:53 2 years ago 157 Скачать Далее
Ovarian Cancer: Standards of Care and New Opportunities - Dr. Robert Coleman HMP Education 33:15 11 years ago 1 395 Скачать Далее
